Hydronephrosis, defined as dilation of the renal pelvis and calices, is a common disease, found in 1.5--3.3% of autopsies[@b1]. In the most severe cases, kidney function is lost as a result of complete destruction of the renal parenchyma. Obstruction of urine flow at any point along the urinary tract causes retention of urine and increased hydrostatic pressure in the renal pelvis and calices, which is one of the known causes of hydronephrosis. The prevalence of antenatal hydronephrosis was reported to be in the range of 1--5% of pregnancies diagnosed by the use of fetal ultrasonography[@b2]. While the underlying etiologies of antenatal hydronephrosis are considered to be diverse, most cases lack obstruction[@b3][@b4]. Nonobstructive hydronephrosis is clinically defined by the absence of urinary tract obstruction and vesicoureteral reflux. However, its molecular pathophysiology is unclear.

Certain types of chemical agents induce hydronephrosis. Administration of lithium chloride results in hydronephrosis in mouse neonates[@b5]. Drugs such as mitomycin[@b7] and adriamycin[@b8] are also known to produce hydronephrosis. Dioxins, a group of halogenated aromatic hydrocarbons, induce hydronephrosis in rodent fetuses and neonates[@b6]. They are produced during combustion processes and are ubiquitously present in the environment. They bioaccumulate in humans and wild animals[@b9] and have a variety of toxic effects, including teratogenicity, reproductive toxicity, neurobehavioral disorders, immune dysfunction, and carcinogenicity[@b6]. The most potent congener among dioxins is 2,3,7,8-tetrachlorodibenzo-*p*-dioxin (TCDD). TCDD administration induces hydronephrosis in rodents when they are exposed to it during gestation or via lactation[@b10][@b11][@b12]. A pathological characteristic of TCDD-induced hydronephrosis in mouse neonates is the absence of ureteral morphological obstruction[@b13]. Therefore, TCDD-induced hydronephrosis is a potential model of nonobstructive hydronephrosis in mammals. Another important characteristic is that the critical exposure period leading to the development of TCDD-induced hydronephrosis is confined to the perinatal period[@b14][@b15], which makes TCDD-induced hydronephrosis a potential model of the perinatal hydronephrosis that is frequently found in human fetuses[@b3][@b4].

The toxic effects of dioxins, including hydronephrosis, are mediated by aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor. AhR is essential for dioxin toxicity as is demonstrated by the absence of toxicity in AhR-null mice[@b13][@b16][@b17][@b18]. Several genes in addition to that for AhR have been shown to be involved in dioxin toxicity[@b19]. Among them, genes encoding enzymes for the production of prostaglandins are responsible for the onset of TCDD-induced neonatal hydronephrosis in mice[@b13][@b20]. AhR-dependent upregulation of COX-2 plays a critical role in the onset of hydronephrosis induced by lactational exposure to TCDD in mice. COX-2 upregulation by TCDD is AhR-dependent *in vivo* and the requirement for COX-2 was confirmed by the abrogation of TCDD-induced hydronephrosis by a COX-2-selective inhibitor[@b13]. COX-2 is an inducible form of cyclooxygenase, which converts arachidonic acid to prostaglandin H~2~ (PGH~2~). Microsomal prostaglandin E synthase-1 (mPGES-1) transforms PGH~2~ to prostaglandin E~2~ (PGE~2~) and is required for TCDD-induced hydronephrosis, as demonstrated by the lack of hydronephrosis in mPGES-1-null mice[@b20]. These studies indicate that PGE~2~ production, mediated by COX-2 and mPGES-1, plays a key role in the onset of TCDD-induced hydronephrosis.

In the present study, we hypothesized that there is at least one upstream mediator that is necessary for the TCDD-induced upregulation of COX-2 and/or mPGES-1. Such a mediator is thought to affect the pathogenesis of TCDD-induced hydronephrosis via an increase in the production of PGE~2~. Arachidonic acid, the substrate of COX-2, is one of the main precursors of eicosanoids, including leukotrienes, thromboxanes, and prostaglandins. Phospholipase A~2~ (PLA~2~) enzymes catalyze the hydrolysis of membrane phospholipids to release arachidonic acid[@b21]. Of more than 30 enzymes with PLA~2~ activity, cytosolic phospholipase A~2~α (cPLA~2~α) is transcriptionally upregulated[@b22][@b23] or enzymatically activated[@b24] in response to TCDD exposure. Upregulation and/or activation of cPLA~2~α can modulate a number of biological processes through arachidonic acid-derived eicosanoids, including PGE~2~. Therefore, cPLA~2~α has the potential to mediate the toxic effects in response to TCDD exposure. The present study examined the possible role(s) of cPLA~2~α in the onset of TCDD-induced hydronephrosis and in the upregulation of COX-2 and mPGES-1.

Results
=======

Role of cPLA~2~α in TCDD-induced hydronephrosis
-----------------------------------------------

To investigate the potential role of cPLA~2~α in the onset of TCDD-induced hydronephrosis in mouse neonates, cPLA~2~α KO mice were produced by mating heterozygous cPLA~2~α KO mice with each other. After delivery, dams were administered TCDD (20 μg/kg) or vehicle on PND 1, and consequently WT \[cPLA~2~α (+/+)\] and KO \[cPLA~2~α (−/−)\] pups were exposed to TCDD through lactation. The cPLA~2~α KO pups did not show any overt abnormality until PND 14 when they were sacrificed for analyses. The body weight of the TCDD-exposed KO pups and that of the WT pups were similar to each other on PND 14 (6.25 ± 0.41 g in female WT pups vs 6.30 ± 0.50 g in female KO pups, and 6.39 ± 0.27 g in male WT pups vs 6.83 ± 0.25 g in male KO pups), which indicates that the KO pups were fed normally and suggests that these two groups of mice were exposed to a similar dose of TCDD via milk. This supposition was confirmed by the nearly identical expression levels of the AhR target genes, CYP1A1[@b25], AhRR[@b26], and IGFBP-1[@b27], upon TCDD exposure between the groups of KO pups and WT pups ([Fig. 1A--C](#f1){ref-type="fig"} and [Supplementary Fig. 1A--C](#s1){ref-type="supplementary-material"}).

In histological examination, compared with the normal morphology of kidneys from vehicle-treated WT pups ([Fig. 2A](#f2){ref-type="fig"}) and that of KO pups ([Fig. 2C](#f2){ref-type="fig"}), the most severe degree of hydronephrosis was found in TCDD-exposed WT pups ([Fig. 2B](#f2){ref-type="fig"}), while only modest ([Fig. 2D](#f2){ref-type="fig"}) or no effects were observed in TCDD-exposed KO pups. Incidence and severity of hydronephrosis were examined in TCDD-exposed WT and KO pups and control pups on PND 14. All TCDD-exposed female ([Table 1](#t1){ref-type="table"}) and male ([Supplementary Table 1](#s1){ref-type="supplementary-material"}) WT pups developed hydronephrosis by PND 14 and most mice of both sexes showed the most severe degree of hydronephrosis ([Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"}). By contrast, the incidence of hydronephrosis in TCDD-exposed female and male cPLA~2~α KO pups on PND 14 was 33% and 36%, respectively, and none showed the most severe degree of hydronephrosis ([Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"}). No hydronephrosis was observed in female and male control pups ([Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"}). These results demonstrate that a lack of cPLA~2~α markedly reduces the incidence and severity of TCDD-induced neonatal hydronephrosis.

Role of cPLA~2~α in upregulation of the PGE~2~ production pathway
-----------------------------------------------------------------

The possible role of cPLA~2~α in the TCDD-induced increase in PGE~2~ synthesis was examined on PND 7. This time point was chosen because TCDD-induced increase in urinary PGE~2~, and upregulation of enzymes responsible for the PGE~2~ production, COX-2 and mPGES-1, are prominent on PND 7[@b13][@b20]. In female TCDD-exposed WT pups, COX-2 mRNA abundance, mPGES-1 mRNA abundance, and urinary PGE~2~ concentration were significantly increased 5.5, 6.1, and 13.3 fold, respectively, compared with those in the control pups ([Fig. 3A--C](#f3){ref-type="fig"}). In female TCDD-exposed KO pups, COX-2 mRNA abundance, mPGES-1 mRNA abundance, and urinary PGE~2~ concentration were 1.9, 1.6, and 2.2 fold, respectively, compared with those in the vehicle-treated KO pups, and none of these increase was significant ([Fig. 3A--C](#f3){ref-type="fig"}). The TCDD-dependent fold induction of COX-2 mRNA, mPGES-1 mRNA, and urinary PGE~2~ concentration in female cPLA~2~α KO pups was significantly reduced by 74%, 65%, and 84%, respectively, compared with those in female WT mice. The degree of such reductions by the genetic ablation of cPLA~2~α was comparable to the degree of suppression in the incidence of TCDD-induced hydronephrosis (i.e., 67%). Essentially the same results were observed in TCDD-exposed male pups. TCDD exposure considerably increased abundance of COX-2 and mPGES-1 mRNAs and urinary PGE~2~concentration in WT pups, and such increases were suppressed to nearly the control level by genetic ablation of cPLA~2~α ([Supplementary Fig. 2](#s1){ref-type="supplementary-material"}). These results demonstrate that cPLA~2~α plays a predominant role in TCDD-dependent increases in COX-2 and mPGES-1 mRNAs and urinary PGE~2~ excretion in WT C57BL/6J mouse pups.

Changes in gene expression in the kidney associated with TCDD-induced hydronephrosis
------------------------------------------------------------------------------------

We analyzed expression of several genes the deficiency of which have been reported to induce hydronephrosis[@b28][@b29][@b30] and that are downregulated in the kidney of mouse pups exposed to TCDD[@b13][@b20]. In female pups on PND 7, expression of mRNAs of electrolyte transporters, Na-K-Cl cotransporter 2 (NKCC2) and renal outer medullary K channel (ROMK), were significantly downregulated in the TCDD-exposed WT pups (46% and 32%, respectively) compared with those in the vehicle-treated WT pups ([Figs. 4A and B](#f4){ref-type="fig"}). Expression of mRNA for a water channel, aquaporin 2 (AQP2), in the TCDD-exposed WT pups was also significantly reduced to 50% compared with the vehicle-control WT pups ([Fig. 4C](#f4){ref-type="fig"}). In particular, no such decreases in NKCC2, ROMK, and AQP2 mRNAs were observed in cPLA~2~α KO pups ([Fig. 4](#f4){ref-type="fig"}). In male WT and cPLA~2~α KO pups ([Supplementary Fig. 3](#s1){ref-type="supplementary-material"}), lactational exposure to TCDD led to results essentially identical to those observed in the above-described female pups ([Fig. 4](#f4){ref-type="fig"}).

CYP1A1, AhRR and IGFBP-1 mRNAs were quantified to monitor AhR transactivation activity and found to be significantly increased by TCDD exposure not only in female WT pups but also in female cPLA~2~α KO pups ([Fig. 1A--C](#f1){ref-type="fig"}). The expression level of these AhR dependent genes were used as surrogate marker of TCDD exposure as already described above. Essentially, the same result was observed in male pups ([Supplementary Fig. 1](#s1){ref-type="supplementary-material"}), although the difference in IGFBP-1 mRNA abundance was not statistically significant probably due to a low induction level by TCDD. The abundance of cPLA~2~α mRNA was increased by TCDD exposure in female and male WT pups ([Fig. 1D](#f1){ref-type="fig"} and [Supplementary Fig. 1D](#s1){ref-type="supplementary-material"}, respectively), but was barely detected in female and male KO pups, possibly reflecting the expression of a truncated cPLA~2~α lacking enzymatic activity[@b31].

Discussion
==========

This study was performed to elucidate the possible roles of cPLA~2~α, a member of PLA~2~ enzyme family, in the pathogenesis of hydronephrosis in mouse neonates caused by lactational exposure to TCDD. Heterozygous female and male cPLA~2~α KO mice were mated, and the resulting dams were given TCDD on PND 1 at a dose sufficient to induce hydronephrosis in all WT pups by PND 14. In contrast to WT pups, only 33% of female and 36% of male cPLA~2~α KO pups showed signs of hydronephrosis ([Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"}). This marked reduction in the incidence of hydronephrosis by genetic ablation of cPLA~2~α, as well as the concurrent reduction in PGE~2~ excretion in the urine, i.e., 84% in KO females and 72% in KO males, compared with the WT pups, demonstrates a significant role of cPLA~2~α in the onset of TCDD-induced neonatal hydronephrosis, and suggests that cPLA~2~ is the major player among many other PLA~2~ enzymes in this role.

Approximately one-third of female and male cPLA~2~α KO pups developed hydronephrosis upon TCDD exposure, although the degree of hydronephrosis was much less severe than those in female and male WT pups ([Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"}). The mechanism by which TCDD-exposure developed hydronephrosis in cPLA~2~α KO neonates is thought to be dependent on PGE~2~ because of the following two reasons. (1) Genetic ablation of mPGES-1, a PGE~2~ synthase, completely blocks the onset of hydronephrosis in TCDD-exposed mouse neonates[@b20], which demonstrates PGE~2~ is essential for the pathogenesis. (2) Synthesis of PGE~2~ is not completely blocked in the cPLA~2~α KO pups ([Fig. 3C](#f3){ref-type="fig"} and [Supplementary Fig. 2C](#s1){ref-type="supplementary-material"}), and the minor increase in PGE~2~ could elicit onset of the less severe hydronephrosis.

Another important finding of this study is that cPLA~2~α is necessary for the TCDD-induced upregulation of the expression of COX-2 and mPGES-1. The indispensable roles of these two enzymes in the TCDD-induced neonatal hydronephrosis were previously demonstrated by pharmacological inhibition of COX-2[@b13] and by genetic ablation of mPGES-1[@b20]; each of these treatments completely abolished TCDD-induced hydronephrosis. These studies also revealed that TCDD exposure upregulates the mRNA expression of both COX-2 and mPGES-1 *in vivo*, but did not clarify the component that mediates upregulation of the two genes. The present study showed that cPLA~2~α has a role to mediate TCDD-induced upregulation of COX-2 and mPGES-1 expression, because the TCDD-induced upregulation of COX-2 and mPGES-1 mRNAs was markedly reduced in the absence of cPLA~2~α ([Fig. 3](#f3){ref-type="fig"} and [Supplementary Fig. 2](#s1){ref-type="supplementary-material"}). It has been established that the expression of CYP1A1[@b25], AhRR[@b26] and IGFBP-1[@b27] is induced by a canonical AhR signaling pathway (also referred to as a genomic action pathway of AhR) because they require the transactivation activity of AhR for their expression in response to TCDD. TCDD-induced increase in mRNA abundance of CYP1A1, AhRR and IGFBP-1 was not influenced by the presence or absence of cPLA~2~α ([Fig. 1](#f1){ref-type="fig"} and [Supplementary Fig. 1](#s1){ref-type="supplementary-material"}), while that of COX-2 and mPGES-1 was dependent on cPLA~2~α, indicating that the upregulation mechanism of these three genes is distinct from that of COX-2 and mPGES-1.

Two distinct cPLA~2~α pathways in AhR signaling can mediate responses to TCDD. The first pathway, referred to as the genomic action pathway[@b24], is well established and is the basis of a dogma to explain TCDD toxicity. This response requires translocation of the TCDD-AhR complex into the nucleus to form a heterodimer with the AhR nuclear translocator (ARNT)[@b25], which upregulates a number of genes, including CYP1A1[@b25], AhRR[@b26] and IGFBP-1[@b27]. The cPLA~2~α gene is also expected to be a target of the genomic action pathway of AhR for the following reasons: the gene has an AhR binding site in its intron[@b23], and the TCDD-induced increase in cPLA~2~α mRNA is dependent on AhR in hepatoma-derived cell lines[@b22][@b23]. The second pathway of AhR, on the other hand, does not require dimerization of AhR with ARNT or binding of the AhR-ARNT-ligand complex to the promoter region of its target genes; it is named the nongenomic AhR pathway[@b24]. This response requires phosphorylation of cPLA~2~α through activation of protein kinases upon Ca^2+^ influx, as has been demonstrated in MMDD1 cells[@b32] and several other cell lines[@b24]. As a logical consequence, a question arises about the dominance of either the genomic or the nongenomic AhR pathway in the pathogenesis of TCDD-induced hydronephrosis. However, the question has not been explored yet because an appropriate experimental model to differentiate the two mechanisms on TCDD toxicity via cPLA~2~α is unavailable. The present study demonstrated for the first time that TCDD-induced neonatal hydronephrosis is a suitable model to explore the question because this toxicity phenotype was revealed to be dependent on cPLA~2~α, which mediates both genomic and nongenomic actions of AhR.

Three enzymes, cPLA~2~α, COX-2, and mPGES-1, are the main components of the PGE~2~ synthesis pathway. In this pathway, cPLA~2~α catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid, which is then converted to PGH~2~ by COX-2. PGH~2~ is converted to PGE~2~ by mPGES-1. TCDD activates this pathway. These three enzymes were upregulated in the kidneys of mouse pups exposed to TCDD, and the PGE~2~ concentration in the urine was increased ([Figs. 1](#f1){ref-type="fig"} and [3](#f3){ref-type="fig"}, and [Supplementary Figs. 1 and 2](#s1){ref-type="supplementary-material"}). The indispensable roles of COX-2[@b13] and mPGES-1[@b20] and the crucial role of cPLA~2~α (demonstrated in the present study) clearly indicate that PGE~2~ elicits TCDD-induced neonatal hydronephrosis. The next step in elucidating the pathogenesis pathway of TCDD-induced neonatal hydronephrosis will be to identify a receptor for PGE~2~ responsible for the onset of hydronephrosis, and to characterize the biological components downstream of the PGE~2~ receptor. Electrolyte transporters NKCC2 and ROMK and a water channel AQP2 are presumably the candidate components, since the lack of them can result in polyuria leading to the onset of hydronephrosis[@b28][@b29][@b30].

A variety of biological phenomena, such as reproduction, cancer, immune responses, and atherosclerosis, are influenced by cPLA~2~α through the production of eicosanoids, such as prostaglandins, thromboxanes, and leukotrienes, which are metabolites of arachidonic acid[@b21]. Using hydronephrosis as a model, we demonstrate for the first time that cPLA~2~α is involved in the pathogenesis of TCDD toxicity. Given that the expression of cPLA~2~α is deregulated by TCDD ([Fig. 1D](#f1){ref-type="fig"} and [Supplementary Fig. 1](#s1){ref-type="supplementary-material"}), other cPLA~2~α-related phenomena could be disrupted through changes in eicosanoid levels. TCDD exposure was recently reported to alter the levels of many eicosanoids in several organs[@b33], although the impact of the alterations on a variety of the endpoints of TCDD toxicity remains to be identified.

In conclusion, we have shown that cPLA~2~α predominantly affect the onset of TCDD-induced neonatal hydronephrosis, and is responsible at least partly for the TCDD-induced increase in mRNAs of COX-2 and mPGES-1. The identification and characterization of downstream components of the cPLA~2~α/COX-2/mPGES-1 pathway will clarify the molecular mechanisms underlying the pathogenesis not only of TCDD-induced neonatal hydronephrosis, but also human nonobstructive hydronephrosis induced by yet uncharacterized mechanisms.

Methods
=======

Animals and treatment
---------------------

A TCDD solution (50 μg/mL in n-nonane) was purchased from Cambridge Isotope Laboratory (Andover, MA, USA) and diluted in corn oil (Wako Pure Chemicals, Osaka, Japan). Corn oil containing 2% n-nonane was used as vehicle.

C57BL/6J strain mice were purchased from CLEA Japan (Tokyo, Japan). cPLA~2~α-null mice were generated as described previously[@b31], and backcrossed more than 12 times in the laboratory of T. Shimizu and more than 4 times in the laboratory of C. Tohyama. Mice were housed at 23 ± 1°C and 50 ± 10% humidity on a 12/12 h light--dark cycle. Laboratory rodent chow (Labo MR Stock; Nosan, Yokohama, Japan) and distilled water were provided *ad libitum*. The study protocols were approved by the Animal Care and Use Committee of the Graduate School of Medicine, The University of Tokyo.

Heterozygous cPLA~2~α knockout (KO) mice on the C57BL/6J background were mated to produce WT \[cPLA~2~α (+/+)\] and homozygous KO \[cPLA~2~α (−/−)\] mice. Parturition was checked twice daily, and the day of birth was designated postnatal day 0 (PND 0). Dams were orally administered either a single dose of TCDD (20 μg/kg, 20 mL/kg body weight) or an equivalent volume of vehicle on PND 1. Consequently, pups were exposed to TCDD via lactation, and were sacrificed on PND 7 or PND 14 to collect the kidneys and urine from the bladder. The numbers of dams and pups used for gene expression analysis on PND 7 were 6 and 4--6, respectively, for the vehicle groups, and 5 and 4--5, respectively, for the TCDD groups. The pups used for histological analysis on PND 14 are described in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}. Data derived from individual pups of the same sex, age, genotype, and TCDD dose were averaged within a litter and then averaged across litters.

The genotypes of the mice (WT or cPLA~2~α KO) were determined using PCR to amplify genomic DNA collected from tail snips using the primer sequences CTCTGGTGTGATGAAGGCACTCTATGAGTC and CCCTACCTACAATGTTCACCCAAAACTAGC for WT \[cPLA~2~α (+/+)\], and TCGTGCTTTACGGTATCGCCGCTCCCGATT and CCCTACCTACAATGTTCACCCAAAACTAGC for KO \[cPLA~2~α (−/−)\] mice.

Histology of the kidney
-----------------------

Kidney specimens were fixed in 10% neutral-buffered formalin, cryoprotected in 20% sucrose solution, embedded in O.C.T. compound (Sakura Finetek Japan, Tokyo, Japan), and snap-frozen in liquid nitrogen. Tissues were sectioned (5-μm thick sections) and stained with hematoxylin and eosin.

Hydronephrosis severity scores were assigned using a previously described scoring system, ranging from '0 = no hydronephrosis' to '+4 = the most severe hydronephrotic kidney'[@b34]. For determining the severity score, blind scoring was performed for all samples (vehicle/TCDD and WT/KO). Incidence of hydronephrosis in the pups was calculated as the percentage of pups with a severity score ≥2 on either the left or right kidney, in accordance with previous reports[@b34][@b35].

Quantitative RT-PCR
-------------------

Total RNA was isolated from the kidneys using the RNeasy Mini Kit (Qiagen, Tokyo, Japan). cDNA synthesis of a given mRNA was performed using an oligo-dT~20~ primer and SuperScript III (Invitrogen, Carlsbad, CA, USA).

Gene expression levels were quantitatively determined using a LightCycler System (Roche Molecular Biochemicals, Indianapolis, IN, USA) with the Thunderbird SYBR qPCR Mix (Toyobo, Osaka, Japan). Primers for the genes ([Table 2](#t2){ref-type="table"}) were designed from the respective cDNA or mRNA sequences using Primer3 software[@b36]. No-template controls were analyzed in every PCR to monitor cross-contamination. To verify amplification specificity, melting curve analyses of the products were performed for every PCR. The mRNA expression levels were calculated using the ΔΔC~t~ method and normalized to cyclophilin B expression.

PGE~2~ measurement
------------------

Urine was collected from the bladders of 7-day-old mice using a syringe. Urinary PGE~2~ concentrations were measured using a Prostaglandin E2 EIA kit (Cayman Chemical, Ann Arbor, MI, USA).

Data analysis
-------------

To normalize possible litter effects, the data for individual pups of the same sex, age, genotype, and TCDD dose were averaged within a litter and then averaged across litters. All data are expressed as the mean ± SEM for the indicated numbers of litters. Differences in means were analyzed by one-way analysis of variance (ANOVA) followed by Tukey-Kramer post hoc analysis. The statistical significance level was set at \<0.05.
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![cPLA~2~α-dependent and -independent increases in gene expression in 7-day-old female pups lactationally exposed to TCDD.\
CYP1A1 (A), AhRR (B), IGFBP-1 (C) and cPLA~2~α (D) mRNA abundances in the kidney after normalizing to the cyclophilin B mRNA level. Results are presented as mean ± SEM for 4--6 dams/group. Histograms with different letters indicate a statistically significant difference at P \< 0.05 by one-way ANOVA with the post hoc test. No statistical comparison was performed for cPLA~2~α KO pups expressing truncated cPLA~2~α[@b31].](srep04042-f1){#f1}

![Representative pictures of cPLA~2~α-dependent hydronephrosis on PND 14 induced by lactational exposure to TCDD in male pups.\
Dams were administered TCDD (20 μg/kg) on PND 1. Kidney of vehicle-exposed cPLA~2~α (+/+) (A) and cPLA~2~α (−/−) (B) mice and TCDD-exposed cPLA~2~α (+/+) (C) and cPLA~2~α (−/−) (D) mice on PND 14. The degree of hydronephrosis in (B) and (D) was diagnosed as 4 and 2, respectively, using the scale, reported previously[@b34]. Scale bars = 500 μm. Refer to [Table 1](#t1){ref-type="table"} and [Supplementary Table 1](#s1){ref-type="supplementary-material"} for information on all pups examined on PND 14.](srep04042-f2){#f2}

![cPLA~2~α-dependent increase in urinary PGE~2~ production in 7-day-old female pups lactationally exposed to TCDD.\
COX-2 (A) and mPGES-1 (B) mRNA abundances in the kidney on PND 7 are shown after normalizing to the cyclophilin B mRNA level. (C) PGE~2~ concentration in urine. Results are presented as mean ± SEM for 4--6 dams/group. Histograms with different letters indicate a statistically significant difference at *P* \< 0.05 by one-way ANOVA with a post hoc test.](srep04042-f3){#f3}

![cPLA~2~α-dependent alterations in gene expression in 7-day-old female pups lactationally exposed to TCDD.\
NKCC2 (A), ROMK (B), and AQP2 (C) mRNA abundances in the kidney (after normalizing to the cyclophilin B mRNA level) are shown. Results are presented as mean ± SEM for 4--6 dams/group. Histograms with different letters indicate a statistically significant difference at P \< 0.05 by one-way ANOVA with the post hoc test.](srep04042-f4){#f4}

###### Severity and incidence of hydronephrosis in female pups

        Dose (μg/kg)   cPLA~2~αgenotype   N[b](#t1-fn3){ref-type="fn"}(pup/dam)   Severity[c](#t1-fn4){ref-type="fn"}   Incidence[d](#t1-fn5){ref-type="fn"}(%)              
  ---- -------------- ------------------ --------------------------------------- ------------------------------------- ----------------------------------------- --- --- --- --------------------------------
  14         0               +/+                           6/5                                     4                                       2                      0   0   0                 0
             0               −/−                           5/4                                     4                                       1                      0   0   0                 0
             20              +/+                           9/6                                     0                                       0                      1   0   8                100
             20              −/−                           8/6                                     6                                       0                      1   1   0   33[\*](#t1-fn6){ref-type="fn"}

*Note:*

^a^Dams were treated once by gavage on PND 1 and the pups were analyzed for hydronephrosis on PND 14.

^b^Number of pups and dams in each group. Among two groups of mice with different genotypes subjected to the same treatment, dams are counted redundantly.

^c^Number of pups with each severity score. Possible litter effects were not normalized.

^d^Incidence in each group, with normalization by litter to minimize possible litter effects.

\**P* \< 0.05 vs WT. See Experimental Procedures for details.

###### Sequences of primers used for qPCR

  Target Gene                    Primer Sequences (5′ to 3′)
  ----------------- --------- ---------------------------------
  *AhRR*             Forward     CAG GGC AGA CAT TGT GGT TA
                     Reverse     CTC CAT TGC TCT TTC CTG CT
  *AQP2*             Forward     GCT GTC AAT GCT CTC CAC AA
                     Reverse      AGG CAA AGA TGC ACA GCA C
  *COX-2*            Forward   TGT GAA CAA TCA AAC AAA ATG ATG
                     Reverse   GCG TAA ATT CCA ACA GCC TAA GT
  *cPLA~2~α*         Forward     AGC ATT CAA AAG GCT TCA CG
                     Reverse     GGG AAA CAG AGC AAC GAG AT
  *Cyclophilin-B*    Forward     GAC TTC ACC AGG GGA GAT GG
                     Reverse     TGT GAG CCA TTG GTG TCT TTG
  *CYP1A1*           Forward      GGC ACC TCT GTT CAC CCT A
                     Reverse     GAA TCT CTC CCT CTG TTC TTG
  *IGFBP-1*          Forward     GGA ACG CCA TCA GCA CCT AT
                     Reverse     GCA GCT AAT CTC TCT AGC ACT
  *mPGES-1*          Forward      CTC AAG CCC TGC TAC CAC A
                     Reverse     GGC CTC AGA CAA GAG ACC AT
  *NKCC2*            Forward     GCT TTA GAC AAC GCT CTG GAA
                     Reverse     CGC CTG TTA AGA CAA TGC AC
  *ROMK*             Forward     GCC AAG CCC ATT CCT TAG AC
                     Reverse     TCT TCA GCC TCT TCA CCA ACA
